CAMPBELL, Calif. — March 4, 2025 – Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated product companies with its...
Portfolio
Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ear, nose and throat (ENT) and allergy treatments,...
